The current analyst and expert consensus on Juno Therapeutics is Hold with 7 hold recommendations. The current projected target price consensus is 35.89 with 9 analysts opinions. One of the most common ways Juno Therapeutics analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Juno Therapeutics vendors, executives, and/or customers. Juno Therapeutics recommendation module provides expert sentiment on the projected Juno Therapeutics target price to derive its highest and lowest estimates based on target price standard deviation of 9.739. Please also check Risk vs Return Analysis.